Michael KadesDirector, Markets and Competition Policy, Washington Center for Equitable GrowthSubcommittee on Competition Policy, Antitrust, and Consumer Rights:Prescription for Change: Cracking Down on Anticompetitive Conduct in Prescription Drug Markets
July 13, 2021
Thank you, Chairwoman Klobuchar and Ranking Member Lee, for the opportunity to testify about the critical issues of competition and prescription drug markets. Antitrust is, to quote Sen. Klobuchar, “cool again.” The president’s executive order signed last Friday and his accompanying remarks are testament that we are in an antitrust moment as dramatic as any since 1914, when Congress passed the Clayton Act and created the Federal Trade Commission.
All too often in the press or on social media, competition andRead More »